Markets:

Overview

News

Currencies

International

Treasuries

Kymera Therapeutics, Inc. - Common Stock (NQ:KYMR)

85.72 -1.63 (-1.87%)

Streaming Delayed Price Updated: 10:22 AM EDT, Apr 10, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Kymera Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

Kymera Therapeutics Announces Fourth Quarter and Full Year 2022 Financial Results and Provides a Business Update

February 23, 2023

From Kymera Therapeutics, Inc.

Via GlobeNewswire

Kymera Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results on February 23

February 01, 2023

Company also presenting at upcoming investor conferences

From Kymera Therapeutics, Inc.

Via GlobeNewswire

X-Chem and Kymera Expand Existing Partnership

January 31, 2023

From X-Chem

Via Business Wire

What 4 Analyst Ratings Have To Say About Kymera Therapeutics ↗

December 06, 2022

Via Benzinga

Looking Into Kymera Therapeutics's Return On Capital Employed ↗

November 22, 2022

Via Benzinga

Where Kymera Therapeutics Stands With Analysts ↗

November 08, 2022

Analysts have provided the following ratings for Kymera Therapeutics (NASDAQ:KYMR) within the last quarter:

Via Benzinga

Kymera Therapeutics Shares Key 2023 Goals to Support its Evolution into a Fully Integrated Degrader Medicines Company

January 10, 2023

From Kymera Therapeutics, Inc.

Via GlobeNewswire

Kymera Appoints Ellen Chiniara, J.D., as Chief Legal Officer and Corporate Secretary

January 04, 2023

From Kymera Therapeutics, Inc.

Via GlobeNewswire

Kymera Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2023

January 03, 2023

From Kymera Therapeutics, Inc.

Via GlobeNewswire

5 Analysts Have This to Say About Kymera Therapeutics ↗

November 08, 2022

Analysts have provided the following ratings for Kymera Therapeutics (NASDAQ:KYMR) within the last quarter:

Via Benzinga

7 Perfect Presents to Gift Your 2023 Stock Portfolio ↗

December 21, 2022

As we leave 2022 behind, these hot stocks to buy have significant potential and serious catalysts as we move into New Year 2023.

Via InvestorPlace

Why Netcapital Shares Are Trading Lower By Over 33%? Here Are 50 Stocks Moving In Wednesday's Mid-Day Session ↗

December 14, 2022

Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares rose 153% to $0.3325 after gaining 14% on Tuesday. Crown ElectroKinetics, last month, posted a Q3 loss of $0.18 per share.

Via Benzinga

These Biotech Stocks Are the Nasdaq's Big Wednesday Winners ↗

December 14, 2022

Business wins are shining the spotlight on these two companies.

Via The Motley Fool

Dear DS Stock Fans, Mark Your Calendars for Dec. 23 ↗

December 14, 2022

Drive Shack (DS) stock is falling hard on Wednesday after the company warned investors of it delisting shares this month.

Via InvestorPlace

Why Is SOFI Stock Up 7% Today? ↗

December 14, 2022

SoFi Technologies (SOFI) stock is climbing higher on Wednesday after the company's CEO bought over 1 million more shares.

Via InvestorPlace

Dear CRKN Stock Fans, Mark Your Calendars for Dec. 22 ↗

December 14, 2022

Crown Electrokinetics (CRKN) stock is on the move Wednesday as investors prepare for the company's upcoming shareholder meeting.

Via InvestorPlace

Why Is Kymera Therapeutics (KYMR) Stock Up 20% Today? ↗

December 14, 2022

KYMR stock traders are bidding up the share price today as Kymera Therapeutics teams up to take a skin condition treatment to the next phase.

Via InvestorPlace

REV Group, Avidity Biosciences And Some Other Big Stocks Moving Higher On Wednesday ↗

December 14, 2022

U.S. stocks traded higher, with the Dow Jones gaining over 100 points on Wednesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Kymera Therapeutics Stock Jumps After Positive Data From Atopic Dermatitis Trial ↗

December 14, 2022

Via Benzinga

US Stocks Higher Ahead Of Fed Decision ↗

December 14, 2022

U.S. stocks traded higher this morning, with the Dow Jones gaining over 80 points on Wednesday

Via Benzinga

Why Small Biotech Kymera Just Snagged Sanofi's Interest And Surged 28% ↗

December 14, 2022

The company is working on protein degradation in cancer and inflammatory diseases.

Via Investor's Business Daily

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

December 14, 2022

Via Benzinga

Kymera Announces Positive Results from Phase 1 Clinical Trial Evaluating KT-474 in Patients with HS and AD and Sanofi’s Decision to Advance KT-474 into Phase 2 Clinical Trials

December 14, 2022

From Kymera Therapeutics, Inc.

Via GlobeNewswire

JetBlue Airways, Pacira BioSciences And Some Other Big Stocks Moving Lower On Tuesday ↗

December 13, 2022

U.S. stocks traded slightly higher, with the Nasdaq Composite gaining around 70 points on Tuesday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Preclinical Data from Kymera Therapeutics’ Collaborations Demonstrate Therapeutic Potential of STAT3 Degraders in CTCL and IRAKIMiD Combination with BCL-2 Inhibitor in MYD88-Mutant DLBCL at the American Society of Hematology Annual Meeting

December 12, 2022

From Kymera Therapeutics, Inc.

Via GlobeNewswire

Kymera Therapeutics Presents Preclinical Data Demonstrating Activity of KT-253, a Selective Heterobifunctional MDM2 Degrader, in Acute Myeloid Leukemia at the American Society of Hematology Annual Meeting

December 11, 2022

From Kymera Therapeutics, Inc.

Via GlobeNewswire

Benzinga's Top Ratings Upgrades, Downgrades For December 6, 2022 ↗

December 06, 2022

Via Benzinga

JPMorgan To Rally Around 17%? Here Are 10 Other Price Target Changes For Tuesday ↗

December 06, 2022

Via Benzinga

Kymera Therapeutics Provides Webcast Information for December 14 Investor Event

December 01, 2022

Company to Share Clinical Data from KT-474 Phase I Patient Cohort and Oncology Pipeline

From Kymera Therapeutics, Inc.

Via GlobeNewswire

Benzinga's Top Ratings Upgrades, Downgrades For November 8, 2022 ↗

November 08, 2022

Upgrades

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.